Skip to main content

Life cycle of Spike Protein

 Entering a Cell

After injection, the vaccine particles bump into cells and fuse to them, releasing mRNA. The cell’s molecules read its sequence and build spike proteins. The mRNA from the vaccine is eventually destroyed by the cell, leaving no permanent trace.



Spike protein coming outside the cell and bumping into antigen presenting cell



Helper T cell being activated


Helper T cell bumping in to B cell and B cell producing antibodies

The S protein is made up of 1,160 to 1,400 amino acids, depending upon the type of virus.

In addition to its role in penetrating cells, the S protein of viruses, particularly the SARS-CoV-2 virus, is a major inducer of neutralizing antibodies (NAbs). NAbs are protective antibodies that are naturally produced by our humoral immune system.

Functional S protein ALLOWS viruses like the novel SARS-CoV-2 to interact with receptors of potential host cells. As a result, the S protein represents an ideal target for vaccine and antiviral drug discovery.

Mechanistic studies indicated that I-S1 of spike protein crosses the blood-brain barrier by adsorptive transcytosis and that murine angiotensin-converting enzyme 2 is involved in brain and lung uptake, but not in kidney, liver or spleen uptake.


Ref:

1. Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020 Apr 16;181(2):281-292.e6. doi: 10.1016/j.cell.2020.02.058. Epub 2020 Mar 9. Erratum in: Cell. 2020 Dec 10;183(6):1735. PMID: 32155444; PMCID: PMC7102599.

2. Rhea EM, Logsdon AF, Hansen KM, Williams LM, Reed MJ, Baumann KK, Holden SJ, Raber J, Banks WA, Erickson MA. The S1 protein of SARS-CoV-2 crosses the blood-brain barrier in mice. Nat Neurosci. 2020 Dec 16. doi: 10.1038/s41593-020-00771-8. Epub ahead of print. PMID: 33328624.


Comments

Post a Comment

Popular posts from this blog

Mounjaro, Is it a game changer for weight loss and diabetes?

  MOUNJARO™ ( Tirzepatide) was approved for medical use in the United States in May 2022 WEIGHT LOSS: (Not approved by FDA for weight loss) Eli Lilly and Company is  finalizing an application to the U.S. Food and Drug Administration for fast-track approval to sell tirzepatide for chronic weight management. MOUNJARO™ is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist indicated in adults for type 2 diabetes mellitus management. CONTRAINDICATIONS Personal or family history of medullary thyroid carcinoma or in patients with Multiple Endocrine Neoplasia syndrome type 2  Known serious all to tirzepatide or any of the excipients in MOUNJARO                                                                    ...
Post a Comment
Read more

Respiratory syncytial virus (RSV) ---cough

Respiratory syncytial virus (RSV) is a leading cause of severe lower respiratory tract disease in young children. Recent RSV strain in Utah is  causing moderate to severe cough (especially during night), weakness and cold-like symptoms .  RSV infection is sometimes severe and is associated with hospitalization, mechanical ventilation, long-term complications, decreased quality of life, loss of work productivity and patient/caregiver stress.  RSV may cause inflammation and infection of small airways and lungs.  Recovery time usually ranges from 7 to 14 days, but RSV can cause serious disease. RSV combined with increasing flu circulation are keeping some hospitals and pharmacies occupied.  Seventeen states are reporting that more than 80% of beds are full, according to the data. Children’s hospitals in Utah, Arizona, the District of Columbia, Maine, Minnesota, Rhode Island, and Kentucky are almost completely at capacity. RSV can spread when viral droplets from a ...
Post a Comment
Read more

Sodium chloride Tablets USP

A 91- year old patient. Admitted to the hospital from the ED. Patient was seen for altered mental status. Labs, CT of brain head, CXR XR of left Tib/Fib were performed. Presumed meningioma in the left middle cranial fossa was noted. Sodium was critically low at 114. Nephrologist was consulted and hyponatremia is of unknown etiology. Patient also has uncontroled hypertension. Comorbidities: Coronary artery disease, Diabetes, Dementia, hypothyroidism, hyperlipedemia, neuropathy. Patient will need physicain oversight for hyponatremia, normal saline routinely, and medication management for hypertension. Rx: Sodium Chloride USP 1.0 gram Use  1. Hyponatremia 2. Preparation of normal isotonic solution of sodium chloride 3. As an electrolyte replenisher for the prevention of heat cramps, due to excessive  perspiration 4. any alternate use as directed by a physician Each tablet contains: sodium 394mg Hyponatremia  is a common electrolyte disorder encountered i...
7 comments
Read more